Reply: Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted
J Am Coll Cardiol
.
2018 Nov 27;72(21):2682-2683.
doi: 10.1016/j.jacc.2018.09.032.
Authors
Yi-Cheng Lin
,
Li-Nien Chien
,
Chun-Yao Huang
PMID:
30466532
DOI:
10.1016/j.jacc.2018.09.032
No abstract available
Publication types
Letter
Comment
MeSH terms
Atrial Fibrillation*
Factor Xa Inhibitors
Humans
Rivaroxaban*
Warfarin
Substances
Factor Xa Inhibitors
Warfarin
Rivaroxaban